Valuation: Astec LifeSciences Limited

Market Cap 1.22TCr 13Cr 11Cr 11Cr 9.56Cr 18Cr 18Cr 125.78Cr 50Cr 639.46Cr 48Cr 47Cr 2.02TCr P/E 2027 *
-43.6x
P/E 2028 * 49.6x
Enterprise Value 1.22TCr 13Cr 11Cr 11Cr 9.56Cr 18Cr 18Cr 125.78Cr 50Cr 639.46Cr 48Cr 47Cr 2.02TCr EV / Sales 2027 *
2.17x
EV / Sales 2028 * 1.64x
Free-Float
26.92%
Yield 2027 *
0.27%
Yield 2028 * 0.23%
1 day-6.11%
1 week-17.80%
1 month-24.52%
3 months-16.75%
6 months-21.47%
Current year-22.62%
1 week 542.5
Extreme 542.5
663.5
1 month 542.5
Extreme 542.5
773.7
Current year 513.4
Extreme 513.4
850
1 year 513.4
Extreme 513.4
941.75
3 years 513.4
Extreme 513.4
1,474.4
5 years 513.4
Extreme 513.4
2,288.8
10 years 305
Extreme 305
2,288.8
Manager TitleAgeSince
Director of Finance/CFO - 01/04/2026
Compliance Officer - 01/11/2018
Chief Operating Officer 56 01/12/2015
Director TitleAgeSince
Chairman 71 25/01/1994
Director/Board Member 56 13/04/2026
Director/Board Member 71 30/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
02/01/25 Buy 1,34,873 0.6877%
02/01/25 Buy

Chairman

4,04,782 2.0640%
02/01/25 Buy 1,34,954 0.6881%
Change 5-day change 1-year change 3-year change Capi.($)
-6.11%-17.80%-17.35%-55.30% 13Cr
+1.26%-0.69%+26.93%+30.18% 3.32TCr
+4.41%+2.17%+48.04%+54.55% 1.87TCr
+0.37%-2.25%-12.30%+28.47% 1.73TCr
-0.52%+5.02%-6.20%-14.05% 1.46TCr
+0.11%-.--%-.--%-.--% 1.3TCr
+0.31%-2.23%+6.69%+7.92% 1.09TCr
-.--%-4.29%-1.12%+149.09% 945.33Cr
-0.22%-.--%-.--%-.--% 829.58Cr
+1.48%-6.51% - - 776.62Cr
Average +0.11%-2.02%+4.97%+22.32% 1.33TCr
Weighted average by Cap. +1.03%+0.04%+12.33%+30.25%

Financials

2027 *2028 *
Net sales 559.5Cr 5.89Cr 5.28Cr 4.85Cr 4.4Cr 8.22Cr 8.38Cr 58Cr 23Cr 294.31Cr 22Cr 22Cr 928.16Cr 740.9Cr 7.8Cr 6.99Cr 6.43Cr 5.82Cr 11Cr 11Cr 77Cr 31Cr 389.73Cr 29Cr 29Cr 1.23TCr
Net income -28Cr -29.38L -26.32L -24.21L -21.93L -41L -41.77L -2.89Cr -1.16Cr -15Cr -1.1Cr -1.08Cr -46Cr 25Cr 25.91L 23.2L 21.34L 19.34L 36.15L 36.83L 2.55Cr 1.02Cr 13Cr 97.23L 95.16L 41Cr
Net Debt - -
Projected Income Statement - Annual - Astec LifeSciences Limited
Logo Astec LifeSciences Limited
Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.
Employees
471
Date Price Change Volume
30/26/30 ₹545.55 -6.11% 75,779
29/26/29 ₹581.05 -3.63% 74,478
28/26/28 ₹602.95 -6.30% 1,08,567
27/26/27 ₹643.50 -1.43% 1,14,395
26/26/26 ₹652.85 -1.63% 39,138
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Astec LifeSciences Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
545.55INR
Average target price
670.00INR
Spread / Average Target
+22.81%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Astec LifeSciences Limited
  1. Stock Market
  2. Stocks
  3. ASTEC Stock